2024-02-01 2025-01-31 false Capium Accounts Production 1.1 09405476 2024-02-01 2025-01-31 09405476 bus:FullAccounts 2024-02-01 2025-01-31 09405476 bus:FRS102 2024-02-01 2025-01-31 09405476 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 09405476 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 09405476 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 09405476 2024-02-01 2025-01-31 09405476 2025-01-31 09405476 bus:RegisteredOffice 2024-02-01 2025-01-31 09405476 core:WithinOneYear 2025-01-31 09405476 core:AfterOneYear 2025-01-31 09405476 1 2024-02-01 2025-01-31 09405476 bus:Director1 2024-02-01 2025-01-31 09405476 bus:Director1 2025-01-31 09405476 bus:Director1 2023-02-01 2024-01-31 09405476 bus:Director2 2024-02-01 2025-01-31 09405476 bus:Director2 2025-01-31 09405476 bus:Director2 2023-02-01 2024-01-31 09405476 2023-02-01 09405476 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 09405476 2023-02-01 2024-01-31 09405476 2024-01-31 09405476 core:WithinOneYear 2024-01-31 09405476 core:AfterOneYear 2024-01-31 09405476 bus:EntityAccountantsOrAuditors 2023-02-01 2024-01-31 09405476 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 09405476 bus:OrdinaryShareClass1 2025-01-31 09405476 bus:OrdinaryShareClass1 2023-02-01 2024-01-31 09405476 bus:OrdinaryShareClass1 2024-01-31 09405476 core:MotorCars 2024-02-01 2025-01-31 09405476 core:MotorCars 2025-01-31 09405476 core:MotorCars 2024-01-31 09405476 core:ComputerEquipment 2024-02-01 2025-01-31 09405476 core:ComputerEquipment 2025-01-31 09405476 core:ComputerEquipment 2024-01-31 09405476 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 09405476 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-31 09405476 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 09405476 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 09405476 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 09405476 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 09405476 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 09405476 core:Non-currentFinancialInstruments 2025-01-31 09405476 core:Non-currentFinancialInstruments 2024-01-31 09405476 core:ShareCapital 2025-01-31 09405476 core:ShareCapital 2024-01-31 09405476 core:RetainedEarningsAccumulatedLosses 2025-01-31 09405476 core:RetainedEarningsAccumulatedLosses 2024-01-31 09405476 dpl:Item1 2024-02-01 09405476 dpl:Item1 2025-01-31 09405476 dpl:Item1 2023-02-01 09405476 dpl:Item1 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09405476


 

 

 

ANBUK HEALTHCARE LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 01 February 2024

End date: 31 January 2025

ANBUK HEALTHCARE LIMITED
Contents Page
For the year ended 31 January 2025
Directors ESTHER OLUWATOYIN SANNI
SIMBIAT ANIKE SANNI
Registered Number 09405476
Registered Office 1 Blueberry Avenue
Manchester
M40 0GE
Accountants VICTOR CHANCE LIMITED
( Chartered Certified Accountants)
1 Blueberry Avenue
Manchester
M40 0GE
Bankers BARCLAYS BANK PLC
Manchester City 2
Leicester
LE87 2BB
1
Director's report and financial statements
The directors present his/her/their annual report and the financial statements for the year ended 31 January 2025.
Principal activities
Principal activity of the company during the financial year was of healthcare services
Directors
The directors who served the company throughout the year were as follows:
ESTHER OLUWATOYIN SANNI (from 26/02/2015)
SIMBIAT ANIKE SANNI (from 24/10/2021)
Statement of directors' responsibilities
The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (Financial Reporting Standard 102). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the companys transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report was approved by the board and signed on its behalf by:


----------------------------------
SIMBIAT ANIKE SANNI
Director

Date approved: 17 September 2025
2
In order to assist you to fulfil your duties under Companies Act 2006, we have prepared for your approval the accounts of ANBUK HEALTHCARE LIMITED for the year ended 31 January 2025 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity and related notes from the company's accounting records and from information and explanations you have given us. This report is made solely to the member of ANBUK HEALTHCARE LIMITED, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of ANBUK HEALTHCARE LIMITED and state those matters that we have agreed to state to the Board of ANBUK HEALTHCARE LIMITED, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ANBUK HEALTHCARE LIMITED and its members as a body for our work or for this report.

It is your duty to ensure that ANBUK HEALTHCARE LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and Profit of ANBUK HEALTHCARE LIMITED. You consider that ANBUK HEALTHCARE LIMITED is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of ANBUK HEALTHCARE LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



....................................................

VICTOR CHANCE LIMITED
( Chartered Certified Accountants)
1 Blueberry Avenue
Manchester
M40 0GE
17 September 2025
3
 
 		 Notes
 		 2025
£		   2024
£
Turnover 95,972    56,916 
Gross profit 95,972    56,916 
Administrative expenses (73,436)   (48,724)
Operating profit 22,536    8,192 
Interest payable and similar charges (193)   (230)
Profit/(Loss) on ordinary activities before taxation 22,343    7,962 
Tax on profit on ordinary activities (4,245)   (1,513)
Profit/(Loss) for the financial year 18,098    6,449 
 
4
 
 		 Notes
 		 2025
£		   2024
£
Fixed assets      
Tangible fixed assets 4 60    60 
60    60 
Current assets      
Cash at bank and in hand 55,105    5,828 
Creditors: amount falling due within one year 5 (35,849)   (3,369)
Net current assets 19,256    2,459 
 
Total assets less current liabilities 19,316    2,519 
Creditors: amount falling due after more than one year 6 (6,019)   (7,717)
Net assets 13,297    (5,198)
 

Capital and reserves 		     
Called up share capital 7 1    1 
Profit and loss account 13,296    (5,199)
Shareholders' funds 13,297    (5,198)
 


For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors on 17 September 2025 and were signed on its behalf by:


-------------------------------
SIMBIAT ANIKE SANNI
Director
5
General Information
ANBUK HEALTHCARE LIMITED is a private company, limited by shares, domiciled in England and Wales, registration number 09405476.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the going concern basis and under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company.
Taxation
The company's liability for corporation tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Dividends
The company paid a total sum of £15,000 as dividend to the shareholders.
Tangible fixed assets
Tangible assets have been fully depreciated. They are represented by a £60 token in the book.
Motor Vehicles 0 Straight Line
Computer Equipment 0 Straight Line
2.

Directors' Emoluments

2025
£		   2024
£
Administrative Expenses
Directors Salaries 23,187    17,500 
23,187    17,500 

3.

Average number of employees

Average number of employees during the year was 2 (2024 : 1).
4.

Tangible fixed assets

Cost or valuation Motor Vehicles   Computer Equipment   Total
  £   £   £
At 01 February 2024 1,500    600    2,100 
Additions -    -    - 
Disposals -    -    - 
At 31 January 2025 1,500    600    2,100 
Depreciation
At 01 February 2024 1,500    540    2,040 
Charge for year -    -    - 
On disposals -    -    - 
At 31 January 2025 1,500    540    2,040 
Net book values
Closing balance as at 31 January 2025 -    60    60 
Opening balance as at 01 February 2024 -    60    60 


5.

Creditors: amount falling due within one year

2025
£		   2024
£
Corporation Tax 4,245    1,513 
Accrued Expenses 850    550 
Other Creditors (1)   1 
Directors' Current Accounts 30,755    1,305 
35,849    3,369 

6.

Creditors: amount falling due after more than one year

2025
£		   2024
£
Bank Loans & Overdrafts (secured) 6,019    7,717 
6,019    7,717 

7.

Share Capital

Authorised
1 Class A share of £1.00 each
Allotted, called up and fully paid
2025
£		   2024
£
1 Class A share of £1.00 each 1    1 
1    1 

8.

Director’s loan

Director Loan

Director Loan balance is £30755 (2023/24: £1305)
6